Preview

Acta Biomedica Scientifica

Advanced search

Risk factors for vascular dementia

https://doi.org/10.29413/ABS.2023-8.3.13

Abstract

Background. An increase in the number of older people with cognitive disorders, including dementia, is expected.

The aim. To study the risk factors for vascular dementia.

Material and methods. 39 patients with vascular dementia (ICD-10 diagnosis code F01) were examined. The comparison group consisted of 167 people. According to the MMSE (Mini Mental State Examination) scale, moderate dementia was detected in 56.4 % of cases, severe – in 43.6 %; in the comparison group, 94 % had mild and 6 % – moderate cognitive impairment.

Results. In the vascular dementia group, the following risk factors were registered significantly more often: ischemic heart disease – at the age of 70–79 years (57.1 %; p = 0.000) and in the group as a whole (56.4 %; p = 0.000); diabetes mellitus – at the age of 60–69 years (100 %; p = 0.005); arterial hypertension – at the age of 70–79 years (100 %; p = 0.000) and in the group as a whole (87.2 %; p = 0.000). In the comparison group, the frequency of body mass index over 25 was significantly higher at the age of 70–79 years (60 %; p = 0.000), 80 years and older (64.3 %; p = 0.037) and in the group as a whole (68.9 %; p = 0.000). Among people with moderate cognitive impairment, the following risk factors were significantly more common: coronary heart disease – at the age of 60–69 years (10 %; p = 0.001); diabetes mellitus – at the age of 70–79 years (40 %; p = 0.025) and in the group as a whole (50 %; p = 0.033), the frequency of body mass index over 25 – at the age of 80 years and older (70 %; p = 0.000) and in the group as a whole (100 %; p = 0.000).

Conclusion. Risk factors for the development of cognitive disorders (coronary heart disease, hypertension, diabetes mellitus, overweight) are potentially reversible; their timely detection can reduce the development of cognitive disorders and dementia.

About the Author

L. A. Ivanova
Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Russian Medical Academy of Continuing Professional Education 
Russian Federation

Lyudmila A. Ivanova – Сand. Sc. (Мed.), Associate Professor at the Department of Psychiatry and Addictology

 Yubileyniy 100, Irkutsk 664079, Russian Federation 



References

1. Kurbanova MM, Galayeva AA, Stefanovskaya YV, Suvorkina AA, Alikhanov NM. Modern methods for the diagnosis of cognitive impairment. Russian Family Doctor. 2020; (1): 35-44. (In Russ.). doi: 10.17816/RFD18986

2. Tkacheva ON, Cherdak MA, Mkhitaryan EA. Examination of patients with cognitive impairments. RMJ. 2017; (25): 1880-1883. (In Russ.).

3. Rodríguez-Sánchez E, Mora-Simón S, Patino-Alonso M. Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study. BMC Neurol. 2011; 11(1): 147. doi: 10.1186/1471-2377-11-147

4. Tkacheva ON (ed.). Program for the prevention, early detection, diagnosis and treatment of cognitive disorders in the elderly and senile age: guidelines. Moscow: Prometei; 2019. (In Russ.).

5. Waldron N, Laws H, James K, Willie-Tyndale D, HolderNevins D, Mitchell-Fearon K, et al. The prevalence of cognitive impairment among older adults in Jamaica. West Indian Med J. 2015; 2(2): 71-76. doi: 10.7727/wimjopen.2014.003

6. Yakhno NN, Zakharov VV, Lokshina AB, Koberskaya NN, Mkhitaryan EA. Dementia: Guidelines; 2rd ed. Moscow: MEDpress-inform; 2011. (In Russ.).

7. Hugo J, Ganguli M. Dementia and cognitive impairment. Clin Geriatr Med. 2014; 30(3): 421-442. doi: 10.1016/j.cger.2014.04.001

8. Behrman S, Valkanova V, Allan CL. Diagnosing and managing mild cognitive impairment. Practitioner. 2017; 261(1804): 17-20.

9. Sanford A. Mild cognitive impairment. Clin Geriatr Med. 2017; 33(3): 325-337. doi: 10.1016/j.cger.2017.02.005

10. Petersen RS, Touchon J. Consensus on mild cognitive impairment: EADC-ADCS. Res Pract Alzheimers Diseas. 2005; 10: 38-46

11. Emelin AYu, Lobzin VYu, Vorobyov SV. Cognitive impairment: Guidelines. Moscow, 2019. (In Russ.).

12. Lokshina AB. Severe dementia: Diagnosis, patient management, prevention of complications. Russian Journal of Psychiatry. 2017; 4: 53-60. (In Russ.).

13. Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Muñoz Sánchez JL, Anstey KJ, et al. Target risk factors for dementia prevention: A systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry. 2015; 30(3): 234-246. doi: 10.1002/gps.4245

14. McGrath ER, Beiser AS, DeCarli C, Plourde KL, Vasan RS, Greenberg SM, et al. Blood pressure from mid- to late life and risk of incident dementia. Neurology. 2017; 89(24): 2447-2454. doi: 10.1212/WNL.0000000000004741

15. SPRINT MIND Investigators for the SPRINT Research Group; Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, et al. Effect of intensive vs standard blood pressure control on probable dementia: A randomized clinical trial. JAMA. 2019; 321(6): 553-561. doi: 10.1001/jama.2018.21442

16. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, BarrettConnor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004; 63(4): 658-663. doi: 10.1212/01.wnl.0000134666.64593.ba

17. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multisystem aging phenotypes: A systematic review and meta-analysis. PLoS One. 2009; 4(1): 41-44. doi: 10.1371/journal.pone.0004144

18. Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, et al. Type 2 diabetes as a risk factor for dementia in women compared with men: A pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016; 39(2): 300-307. doi: 10.2337/dc15-1588

19. Luchsinger JA. Adiposity, hyperinsulinemia, diabetes and Alzheimer’s disease: An epidemiological perspective. Eur J Pharmacol. 2008; 585(1): 119-129. doi: 10.1016/j.ejphar.2008.02.048

20. Cardoso S, Correia S, Santos RX, Carvalho C, Santos MS, Oliveira CR, et al. Insulin is a two-edged knife on the brain. J Alzheimers Dis. 2009; 18(3): 483-507. doi: 10.3233/JAD-2009-1155

21. Albanese E, Launer LJ, Egger M, Prince MJ, Giannakopoulos P, Wolters FJ, et al. Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst). 2017; 8: 165-178. doi: 10.1016/j.dadm.2017.05.007

22. Gorospe EC, Dave JK. The risk of dementia with increased body mass index. Age Ageing. 2007; 36: 23-29. doi: 10.1093/ageing/afl123

23. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009; 1280: 186-194. doi: 10.1016/j.brainres.2009.05.032

24. Kajitani S, Sakata K, McKenzie C. Occupation, retirement and cognitive functioning. Ageing Soс. 2017; 37: 1568-1596.

25. Prince M, Albanese E, Guerchet M, Prina M. World Alzheimer Report 2014. Dementia and risk reduction. An analysis of protective and modifiable factors. 2014.

26. Sommerlad A, Ruegger J, Singh-Manoux A, Lewis G, Livingston G. Marriage and risk of dementia: Systematic review and meta-analysis of observational studies. J Neurol Neurosurg Psychiatry. 2018; 89(3): 231-238. doi: 10.1136/jnnp-2017-316274

27. Evans IEM, Martyr A, Collins R, Brayne C, Clare L. Social isolation and cognitive function in later life: A systematic review and meta-analysis. J Alzheimers Dis. 2019; 70(s1): S119-S144. doi: 10.3233/JAD-180501

28. Farrow M. User perceptions of a dementia risk reduction website and its promotion of behavior change. JMIR Res Protoc. 2013; 2(1): e15. doi: 10.2196/resprot.2372

29. Яхно Н.Н., Ткачев О.Н., Гаврилова С.И., Левин О.С., Боголепова А.Н., Мхитарян Э.А., и др. Комплексная междисциплинарная и межведомственная программа профилактики, раннего выявления, диагностики и лечения когнитивных расстройств у лиц пожилого и старческого возраста до 2025. М.; 2018.

30. Krasilnikov GT, Kosenko VG, Ageyev MI, Shoulkin LM, Kosenko NA, Lomakina GV. Current diagnostic and forensic psychiatric issues of vascular dementia. Sotsial'naya i klinicheskaya psikhiatriya. 2020; (4): 97-107. (In Russ.).

31. Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, et al.; Internationlal Society for Vascular Behavioral and Cognitive Disorders. Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Dis Assoc Disord. 2014; 28(3): 206-218. doi: 10.1097/WAD.0000000000000034


Review

For citations:


Ivanova L.A. Risk factors for vascular dementia. Acta Biomedica Scientifica. 2023;8(3):121-129. https://doi.org/10.29413/ABS.2023-8.3.13

Views: 4188


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2541-9420 (Print)
ISSN 2587-9596 (Online)